Clinical Trial Update: Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% [Phase 1]

View source ↗

Summary

This Phase 1 trial of Ingenol Mebutate Gel 0.05% for actinic keratosis reports histological confirmation of clinical clearance after treatment. The study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate Gel 0.05% (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED